Minimal information for chemosensitivity assays (MICHA): a next-generation pipeline to enable the FAIRification of drug screening experiments

Mostrar otras versiones (1)

Chemosensitivity assays are commonly used for preclinical drug discovery and clinical trial optimization. However, data from independent assays are often discordant, largely attributed to uncharacterized variation in the experimental materials and protocols. We report here the launching of Minimal I...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanoli, Ziaurrehman, Aldahdooh, Jehad, Alam, Farhan, Wang, Yinyin, Seemab, Umair, Fratelli, Maddalena, Pavlis, Petr, Hajduch, Marian, Bietrix, Florence, Gribbon, Philip, Zaliani, Andrea, Hall, Matthew D, Shen, Min, Brimacombe, Kyle, Kulesskiy, Evgeny, Saarela, Jani, Wennerberg, Krister, Vähä-Koskela, Markus, Tang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Problem Solving Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769689/
https://www.ncbi.nlm.nih.gov/pubmed/34472587
http://dx.doi.org/10.1093/bib/bbab350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769689/
https://www.ncbi.nlm.nih.gov/pubmed/34472587
http://dx.doi.org/10.1093/bib/bbab350

Ejemplares similares